Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

A routine physical examination does not allow diagnosing systolic or diastolic LV dysfunction in the preclinical phase (stage B). Similarly, a physical examination cannot accurately characterize the ...

Secondary to hypertension, ventricular hypertrophy and remodeling are frequent causes of diastolic heart failure (HF), a condition associated with morbidity, hospitalization and mortality. Diagnosing ...

Advanced left ventricular diastolic dysfunction (LVDD) in patients undergoing TAVR is linked with almost a fourfold increase in risk of postprocedural death as early as 30 days postprocedure, ...

Left ventricular diastolic dysfunction is associated with worse health status among patients with severe aortic stenosis, but TAVR leads to clinically meaningful symptomatic improvements regardless of ...

Patients with Multiple sclerosis (MS) treated with mitoxantrone (MTX)—an antracyclin drug used to treat chronic refractory MS—may be at an increased risk of developing early and late left ...

Evaluation of NT-proBNP in patients may lead to early exclusion of Left Ventricular dysfunction, according to a new study. The value and cost-effectiveness of screening for left ventricular (LV) ...

Diastolic dysfunction is a heart condition that affects the organ’s capacity to fill with an adequate amount of blood during diastole. Diastole is the phase of the cardiac cycle when the heart relaxes ...

Left ventricular end-diastolic volume is the amount of blood in the heart’s left ventricle just before the heart contracts. While the right ventricle also has an end-diastolic volume, it’s the value ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...